INTRODUCTION 75 76
Herpes simplex virus type 1 (HSV-1) is an alphaherpesvirus that causes 77 recurrent mucocutaneous lesions on the mouth, face, or genitalia, and occasionally 78 meningitis or encephalitis. Saimiriine herpesvirus 1 (designated SaHV-1 in this work) is 79 a primate herpesvirus that belongs to the alphaherpesvirus subfamily and has high 80 sequence similarity to human HSV-1 and HSV2. SaHV-1 was originally isolated from 81 tamarins (Saguinus spp.) that succumbed to lethal generalized disease, however 82 squirrel monkeys (Saimiri spp.) are the natural host for SaHV-1 (1, 2). There have been 83 no confirmed cases of human SaHV-1 infection (3). The recent completion of the SaHV-84 1 genome sequence (3) provided both an impetus to investigate of the function of 85
SaHV-1 entry glycoproteins and a tool to compare the entry of this alphaherpesvirus to 86 provided by Dr. Alberto Severini. FLAG-tagged gB, gD, gH and gL for HSV-1 (pQF112-167 115) and SaHV-1 (pQF081-084) were generated by subcloning the HSV-1 glycoproteins 168 or cloning SaHV-1 viral DNA into pFLAG-myc-CMV-21 expression vector (E5776; 169 Sigma) downstream of the FLAG epitope. The native signal sequences were removed, 170
including HSV-1 gB aa 1-30, SaHV-1 gB aa 1-39, HSV-1 gD aa 1-25, SaHV-1 gD aa 1-171 36, HSV-1 gH aa 1-18, SaHV-1 gH aa 1-29, HSV-1 gL aa 1-19 and SaHV-1 gL aa 1-23. 172
The signal peptides from the SaHV-1 glycoproteins were predicted by using SignalP 4.0 173 Server (http://www.cbs.dtu.dk/services/SignalP/). FLAG-tagged HSV-1 gB, gD, gH and 174 gL were generated by PCR amplification from pPEP98, pPEP99, pPEP100 and 175 pPEP101, respectively. 176 Fig.4A illustrates the FLAG-tagged gD chimeras (pQF122-125, pQF137-139, 177 pQF146, pQF147, pQF152) and deletion mutants (pQF151, pQF153-161) generated by 178 PCR or QuikChange Site-Directed Mutagenesis. pQF144 and pQF148-150 are HSV-1 179 gD PFD point mutants generated by QuikChange Site-Directed Mutagenesis 180 (Stratagene). The amino acids in HSV-1 gD and SaHV-1 gD were numbered after 181 putative signal peptide cleavage. Plasmids made for this study were sequenced by the 182 Northwestern Genomic core facility. 183
Western blots. Western blots of whole lysates were performed to check 184 overall expression of HSV-1 and SaHV-1 glycoproteins. CHO-K1 cells seeded in 6-well 185 plates were transfected with 1.5 μg of empty vector or plasmids expressing FLAG-186 tagged gB, gD, gH and gL from HSV-1 and SaHV-1 using 5 μl of Lipofectamine 2000. 187
After 24 h of incubation, the cells were detached using versene (0.2 g EDTA/liter in 188 9 150 mM NaCl, 5 mM EDTA, 10 mM NaF, 1 mM Na 3 VO 3 , 1% Nonidet P-40) containing 190 protease inhibitors (Roche Diagnostics, Indianapolis, IN). Proteins were separated by 191 SDS-PAGE on 4-20% gels after boiling for 5 min under reducing conditions. Western 192 blot analyses were performed using rabbit anti-FLAG antibodies (Sigma, F7425) at a 193 1:1000 dilution for 1 h at room temperature. Anti-rabbit secondary antibody coupled to 194 horseradish peroxidase (HRP) and ECL™ Western blotting detection reagents (GE 195 Healthcare) were used. and CELISA was performed as described (46). For other gD chimeras and mutants, 203 CHO cells were transfected with all of the plasmids used to prepare effector cells for the 204 cell fusion assays as described below, so that levels of gD expression could be 205 assessed in replicates of the cell populations used in the fusion assays. Six h after 206 transfection, the cells were detached with versene, and suspended in 1.5 ml of F12 207 medium supplemented with 10% FBS. Fifty μl of cell suspension was replated in 208 triplicate in 96-well plates and incubated for 16 h. CELISA was performed using the anti-209 FLAG monoclonal antibody (Sigma F1084). The cells were washed, fixed, and 210 incubated with biotinylated goat anti-mouse IgG (Sigma), followed by streptavidin-HRP 211 (GE Healthcare) and HRP substrate (BioFX). 212 on August 30, 2017 by guest http://jvi.asm.org/
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Cell fusion assay. In parallel with CELISA, cell fusion activity was measured 213 using a quantitative luciferase-based cell fusion assay as previously described (44). 214 CHO-K1 cells were seeded in 6-well plates 1 day before transfection for both effector 215 and target cells. One set of CHO-K1 cells (effector cells) was transfected with 400 ng 216 each of plasmids encoding T7 RNA polymerase, gB, gD, gH and gL using 5 µl of 217 Lipofectamine 2000. In experiments testing heterotypic glycoprotein function, 218 combinations of glycoproteins from HSV-1 or SaHV-1 were transfected, however gH 219 and gL were always derived from the same virus. In experiments testing gD function, 220 wild-type gD was replaced with a gD chimera or mutant. A separate set of CHO-K1 221 cells (effector cells) was transfected with 400 ng of a plasmid encoding the firefly 222 luciferase gene under control of the T7 promoter plus 1.5 µg of empty vector (pcDNA3) 223 or plasmid encoding receptor (PILRα, nectin-1, HVEM, or CD155) using 5 µL of 224 Lipofectamine 2000. Six h after transfection, the cells were detached with versene, and 225 suspended in 1.5 ml of F12 medium supplemented with 10% FBS. Effector and target 226 cells were mixed in a 1:1 ratio and replated in 96-well plates for 18 h. Luciferase activity 227 was quantitated by a luciferase reporter assay system (Promega) using a Wallac-Victor 228 luminometer (Perkin Elmer). 229
230

RESULTS
232
Expression of HSV-1 and SaHV-1 entry glycoproteins. The entry glycoproteins 233 from HSV-1 and SaHV-1 were cloned into an expression vector replacing the 234 glycoprotein signal sequence with a heterologous signal sequence and with the addition 235 of an N-terminal FLAG epitope. Cell surface expression of the glycoproteins was 236 evaluated by transfecting CHO-K1 cells with the construct and using CELISA to detect 237 the FLAG epitope (46, 47) . Since gH requires gL as a chaperone, the two proteins were 238 co-transfected such that only one of the proteins was FLAG-tagged in each transfection. 239
For gD and gB, the FLAG-tagged constructs were transfected alone. High levels of 240 expression of FLAG-tagged gB, gD, gH/gL from HSV-1 and SaHV-1 were readily 241 detected on the cell surface ( Fig 1A) . A western blot of total cell lysate also confirmed 242 expression of the glycoproteins (Fig.1B) . FLAG-tagged gH and FLAG-tagged gL were 243 transfected together and FLAG-tagged gD and gB were transfected separately. Each 244 glycoprotein tested migrated to the expected size. Western blots of all gD chimera, point, 245
and deletion mutants shown in Table 1 and Fig. 4 were performed and the proteins 246 migrated at the expected sizes (data not shown). 247
SaHV-1 can use CD155 and nectin-1, but not HVEM and PILRα in fusion. A 248 quantitative cell-cell fusion assay was used to examine the receptor usage of the SaHV-249 1 entry glycoproteins (Fig. 2) . Target CHO-K1 cells were transfected with a plasmid 250 encoding luciferase under a T7 promoter and either PILRα, nectin-1, HVEM, CD155, or 251 empty vector. Effector CHO-K1 cells were transfected with a plasmid encoding T7 RNA 252 polymerase and gB, gD, gH and gL from either HSV-1 or SaHV-1. Effector and target 253 cells were mixed and luciferase activity was recorded as a measure of cell-cell fusion. 254
Wild-type and flag-tagged constructs exhibited similar levels of fusion (data not shown) 255 and thus the flag-tagged versions were used for subsequent experiments. 256
As expected, HSV-1 glycoproteins mediated fusion with cells expressing nectin-1, 257 HVEM, and PILRα, but not CD155 (17, 48) (Fig. 2) folding, gH/gL was treated as a unit and always derived from the same virus. Nectin-1 274 target cells were used because HSV-1 and SaHV-1 use this receptor to a similar extent 275 (Fig. 2) . 276
Substitution of HSV-1 gD with SaHV-1 gD (or vice versa) resulted in a loss of 277 fusion function (Fig. 3) . Similarly, substitution of HSV-1 gH/gL with SaHV-1 gH/gL (or 278 vice versa) also resulted in a loss of fusion function (Fig. 3) . In contrast, HSV-1 gB and 279
SaHV-1 gB retained some level of fusion function in a heterotypic context. When HSV-280 level seen with the complete set of wild-type SaHV-1 glycoproteins. Similarly, when 282 SaHV-1 gB was coexpressed with HSV-1 gD and gH/gL, fusion was observed at 15% of 283 wild-type HSV-1 levels (Fig. 3) . 284
The ability of gB to function in a heterotypic context may be explained in part by 285 high gB sequence conservation between the viruses (65% amino acid identity). The 286 observation that HSV-1 gD does not mediate fusion in an SaHV-1 background (and vice 287 versa) suggests that the heterotypic gD fails to functionally interact with one or more of 288 the entry glycoproteins. The same can be said for heterotypic gH/gL. Since the two gB 289 proteins are interchangeable to some extent, these results suggests that a homotypic 290 gH/gL-gD functional interaction is required for fusion (Fig. 3) . 291
The gD homotypic requirement for function does not map exclusively to 292 the PFD. To investigate why HSV-1 gD failed to mediate fusion when coexpressed with 293
SaHV-1 gH/gL (and vice versa), we created chimeras of HSV-1 gD and SaHV-1 gD to 294 map potential sites of interaction with gH/gL (Fig. 4A) . We designed the chimeras to 295 examine the PFD because it has been implicated in interactions with other entry 296 glycoproteins (12, 14, 15) . The HSV-1 gD C-terminus (residues 261-369) was replaced 297 with the SaHV-1 gD C-terminus (residues 264-371) including the SaHV-1 profusion 298 domain to generate the construct pQF122. Conversely, the SaHV-1 gD C-terminus was 299 replaced with the HSV-1 gD C-terminus to generate the construct pQF123. Chimeras 300 that swap just the profusion domain were also generated. Construct pQF124 replaces 301 the SaHV-1 gD PFD (residues 264-307) with the HSV-1 gD PFD (residues 261-305) 302 and construct pQF125 replaces the HSV-1 gD PFD with the SaHV-1 gD PFD. 303 on August 30, 2017 by guest http://jvi.asm.org/
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Surface expression of the chimeras was examined by CELISA and western blots 304 were done (data not shown) confirming all of the constructs were expressed at levels 305 similar to wild-type HSV-1 gD (Fig. 5) . The ability of the chimeras to mediate fusion with 306 nectin-1 expressing cells was then determined, with coexpression of either HSV-1 307 gH/gL and gB or SaHV-1 gH/gL and gB (Fig. 5) . 308
When the chimeras were coexpressed with HSV-1 gH/gL and gB, fusion was 309 reduced for all of the chimeras. Unexpectedly, the two chimeras that contain the SaHV-310 1 PFD (pQF122 and pQF125) retained function, whereas the two chimeras with the 311 HSV-1 PFD (pQF123 and pQF124) lost function. These results indicate that the HSV-1 312 PFD and C-terminus are insufficient to support the homotypic HSV-1 requirement. 313
Elements in HSV-1 gD N-terminal to the PFD must contribute to a functional HSV-1 314
When the chimeras were coexpressed with SaHV-1 gH/gL and gB, fusion was 316 retained for all of the constructs except pQF124, the chimera that replaces the SaHV-1 317 PFD with the HSV-1 PFD. A comparison of the results for chimeras pQF124 and 318 pQF123 suggests that the SaHV-1 gD region C-terminal to the PFD (present in pQF123 319 but not pQF124) contributes to the homotypic interaction required for SaHV-1 fusion. 320
Alternatively, the pQF124 chimera may fail to function due to improper folding. The 321 near wild-type levels of cell surface expression for pQF124 suggest that the protein was 322 not globally malfolded, however more modest changes to its folding might impact its 323 function. pQF124 was the only chimera that failed to mediate fusion when coexpressed 324 with either HSV-1 or SaHV-1 glycoproteins, indicating that the majority of the constructs 325 were properly processed. 
glycoproteins. 332
To investigate this further, we created additional gD chimeras based on pQF125. 333
The N-terminus of the SaHV-1 PFD present in pQF125 was progressively replaced by 334 corresponding HSV-1 sequence in constructs pQF137, pQF138, and pQF139 ( Fig. 4A) . 335
The chimeras showed near wild-type surface expression by western blots (data not 336 shown) and CELISA (Fig. 6A) . 337
When coexpressed with SaHV-1 gH/gL and gB, all three of these chimeras failed 338 to function in fusion (Fig. 6A ). All three chimeras mediated fusion when coexpressed 339 with HSV-1 gH/gL and gB, indicating that they were properly folded. This suggests that 340 the residues at the N-terminus of the PFD are critical for the SaHV-1 homotypic 341 interaction. A comparison of the results for chimeras pQF125 and pQF137 indicates 342 that the seven SaHV-1 residues present in pQF125 (SaHV-1 residues 264-270) but 343 absent from pQF137 are required for homotypic function in SaHV-1 fusion. 344 CD155 mediated fusion with cells expressing glycoproteins from SaHV-1 but 345 HSV-1 (Fig. 2) . Surprisingly, when the HSV-1 PFD was replaced with the SaHV-1 PFD 346 (pQF125), fusion activity with CD155 expressing cells increased to 30% of fusion 347 activity of wild-type SaHV-1 gD (Fig. 6B) . The homology between CD155 and nectin-1 348 sequence. The loss of function we observed with pQF137 led us to construct the 356 inverse chimera, pQF146. In pQF146, the SaHV-1 PFD is replaced with HSV-1 PFD 357 except for the first seven amino acids, which remain SaHV-1 (Fig. 4A ). In addition, we 358 generated chimeras in which only the first seven amino acids of the PFD were swapped, 359 pQF147 and pQF152 (Fig. 4A) . Single or double mutations in the first seven HSV-1 360 PFD amino acids were also constructed, focusing on the prolines in this stretch. 361
Residues were mutated either to alanine or the corresponding SaHV-1 residue (Fig. 4A) . 362
Cell surface expression of the chimeras and point mutations was similar to that of 363 WT HSV-1 gD (Fig. 7A) . pQF146 mediated fusion when coexpressed with 364 glycoproteins from SaHV-1 but not HSV-1 (Fig. 7B ). This result supports the notion that 365 the first seven amino acids of the SaHV-1 PFD are critical for function. As determined 366 earlier, pQF124 fails to functionally interact with SaHV-1 glycoproteins. When the first 367 seven amino acids of the HSV PFD were added back to pQF124 to create the pQF146 368 chimera, function with SaHV-1 glycoproteins was restored (Fig. 7B) . 369
Substitution of the first seven amino acids of HSV-1 PFD alone with the residues 370 from the SaHV-1 PFD (pQF147) provided the strongest support for the importance of 371 these residues for SaHV-1 homotypic fusion. pQF147 mediated fusion when 372 on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from coexpressed with SaHV-1 gH/gL and gB (Fig. 7B) , despite the fact only these seven 373 residues originate from the SaHV-1 sequence. The requirements for HSV-1 fusion 374 maps differently. The chimera pQF152, consisting of SaHV-1 gD with the first seven 375 residues of the PFD from HSV-1, failed to mediate fusion when coexpressed with HSV-376 1 gH/gL and gB. Curiously, pQF152 retained function with SaHV-1 glycoproteins, 377
indicating that although the first seven residues of the SaHV-1 PFD are sufficient to 378 drive interaction with SaHV-1 glycoproteins, they are not essential. 379
All of the point mutants (pQF144, pQF148, pQF149, pQF150) retained fusion 380 activity when coexpressed with HSV-1, but none of the mutants gained the ability to 381 functionally interact with SaHV-1 glycoproteins. Thus the ability of pQF147 to interact 382 with SaHV-1 glycoproteins maps to more than just these residues. 383
As expected, chimeras pQF146 and pQF152 can mediate fusion with CD155-384 expressing cells, since both chimeras carry SaHV-1 sequence at the gD-receptor 385 binding site (Fig. 7C) . Since neither chimera functionally interacted with HSV-1 gH/gL 386 and gB, the failure of these chimeras to mediate fusion with CD155-expressing cells 387 when coexpressed with HSV-1 glycoproteins is not surprising. 388
Deletion of the profusion domain abrogates both HSV-1 and SaHV-1 fusion. 389
To further explore the importance of the PFD and regions around the PFD, we made a 390 number of deletion mutants (Fig. 4A) . The first seven residues of the PFD were deleted 391 from HSV-1 gD (pQF151) and SaHV-1 gD (pQF156). The entire PFD also was deleted 392 from HSV-1 and SaHV-1 gD (pQF153 and pQF157, respectively). To examine the 393 importance of the short stretch of residues that links the PFD to the transmembrane 394 region (Fig. 4B) , these membrane-proximal residues were deleted from HSV-1 and 395 on August 30, 2017 by guest http://jvi.asm.org/
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SaHV-1 gD alone (pQF145 and pQF159) or in combination with the PFD deletion 396 (pQF155 and pQF158) . 397
The deletion mutants were all tested for cell surface expression by CELISA. 398
Most of the deletion mutants were expressed at wild-type HSV-1 gD levels, with the 399 exception pQF153, pQF155 and pQF158 (Fig. 8A) . As expected for misfolded proteins, 400 pQF153, pQF155 and pQF158 did not mediate fusion (Fig. 8B and C) . 401
Deletion of the SaHV-1 gD PFD (pQF157) did not alter cell surface expression 402 (Fig. 8A) , but completely abrogated cell fusion ( Fig. 8B and C receptor-binding region (pQF160 and pQF161, respectively) (Fig. 4A) . 420
These PFD-only mutants included the wild-type transmembrane and cytoplasmic 421 domains and were expressed on the cell surface at levels similar to wild-type HSV-1 gD 422 (Fig. 9A) , however neither mutant mediated fusion when coexpressed with homotypic 423 entry glycoproteins (Fig. 9B and 9C) . Thus, unlike for paramyxovirus HN, gD lacking a 424 receptor-binding domain was insufficient to trigger fusion. 425
To investigate whether the receptor binding region and PFD of gD can function 426 independently or whether they must be encoded on the same protein, we tested 427 whether these PFD-only mutants (pQF160 and pQF161) could rescue the fusion activity 428 of the previously examined gD mutants with a deleted PFD (pQF153 and pQF157). 429
Coexpression of the PFD-only and PFD-deleted gD mutants did not rescue fusion for 430
either HSV-1 or SaHV-1 proteins ( Fig. 9B and 9C ), indicating that these regions of gD 431 cannot function independently when encoded on separate proteins. 432
To demonstrate functional activity of these PFD-only and PFD-deleted gD 433 mutants, we tested whether they inhibited fusion mediated by wild-type gD. The 434 mutants were coexpressed with wild-type gD during the fusion assay. For HSV-1, both 435 the PFD-only and PFD-deleted gD mutants for inhibited fusion (Fig. 9B) . Although PFD-436 deleted HSV-1 gD (pQF153) was poorly expressed at the cell surface (Fig. 8A) , 437 expression was sufficient to inhibit fusion. For SaHV-1, the PFD-deleted mutant 438 (pQF157) inhibited more efficiently than the PFD-only mutant (pQF161). The recently published genome sequences of SaHV-1 (3) allowed us to clone gD, 447 gH. gL, and gB from SaHV-1 viral DNA and examine the expression and function of 448 these proteins (Fig. 1) . Cell-cell fusion experiments demonstrated that SaHV-1 uses the 449 entry receptors nectin-1 and CD155, but not PILRα or HVEM (Fig. 2) . conservative changes in two of these residues (Y38F and F223Y). 460
Interestingly, SaHV-1 gD gains the ability to use CD155 as a receptor (Fig. 2) . 461 CD155 is an entry receptor for PRV and BHV1, but not HSV-1 or HSV2 (17). The 462 structural similarity of CD155 and nectin-1 suggests that they would bind to the same 463
CD155. In unpublished cell-cell fusion experiments, we have shown that that B virus 465
and CeHV-1 gD, which are more similar in sequence to HSV-1 gD than SaHV-1 gD, 466 also cannot use CD155 as a receptor. 467
The evolutionary relationships of seven alphaherpesviruses are depicted in a 468 phylogenic tree of the gD sequences (Fig. 10A) . HSV-1 and HSV-2 are very closely 469 related and entry glycoproteins of these two viruses are interchangeable. CeHV-1 470 (cercopithecine herpes virus type 1 or B virus) and CeHV-2 gD are more closely related 471 to HSV-1 gD than is SaHV-1 gD, but SaHV-1 gD is more closely related to HSV-1 gD 472 than either PRV and BHV-1 gD. An amino acid sequence alignment of these seven gD 473 proteins further demonstrates that PRV and BHV-1 are more distantly related than the 474 other five gD homologs (Fig. 10B) . 475
Our results demonstrate that SaHV-1 cannot use HVEM as a receptor (Fig. 2) . 476
Sequence alignment indicates that the lack of HVEM usage is likely due to differences 477 between HSV-1 gD and SaHV-1 gD within the receptor binding region. HVEM binds to 478 gD within an N-terminal hairpin loop on gD (gD residues 7-15 and residues 24-32) (13) . 479
Previous work has demonstrated that an HSV-1 gD Q27P mutation eliminates HVEM 480 receptor usage and an HSV-1 gD L25P mutation reduces HVEM usage (13, 21, 54, 55) . 481
Relative to HSV-1 gD, SaHV-1 gD carries multiple changes in residues shown to 482 contribute to HVEM binding, including M11P, N15A, L25T, and Q27P. The SaHV-1 gD 483 Q27P residue alone would account for the lack of HVEM usage. The pathogenic 484 consequence of HVEM not serving as a receptor remains to be determined. 485
The cell-cell fusion assays demonstrate that SaHV-1 cannot use human PILRα 486 as a receptor (Fig. 2) . Rather than binding to gD like the receptors discussed above, Similarities between the SaHV-1 and HSV-1 sequences led us to examine 497 whether these alphaherpevirus entry glycoproteins would be able to interact with one 498 another functionally. Fusion assays that individually swapped entry glycoproteins 499 between HSV-1 and SaHV-1 demonstrated that both gD and gH/gL have homotypic 500 requirements for fusion, i.e. they cannot function with glycoproteins from the other virus 501 (Fig. 3) . In contrast, gB from either virus was able to mediate fusion when coexpressed 502 with either HSV-1 or SaHV-1 entry glycoproteins. These results implicate a functional 503 homotypic interaction between gD and gH/gL, in agreement with current models of HSV 504 entry (6). This finding provides a framework to examine the sites of the homotypic 505
interaction. 506
To map the sites on gD responsible for its homotypic requirement, a panel of 507 HSV-1 and SaHV-1 gD mutants was created (Fig. 4) . The mutations focused on the gD 508 PFD, a region previously suggested to be the site of gH/gL interaction (15). Of the 45 509 residues in the HSV-1 gD PFD, only 11 residues are identical between HSV-1 and 510
SaHV-1 gD and 24 residues have non-conservative changes (Fig. 4B ). Results 511 demonstrate that the PFD sequence influences the homotypic interaction (Fig. 5 and 6) . 512
For SaHV-1 fusion, seven amino acids at the N-terminus of the PFD were critical for 513 homotypic fusion (Fig. 6 and 7) . Whereas wild-type HSV-1 gD could not mediate fusion 514 when coexpressed with SaHV-1 gH/gL and gB (Fig. 3) , substitution of just the first 515 seven amino acids of the PFD with the corresponding SaHV-1 gD sequence (pQF147) 516 completely rescued its ability to mediate fusion with SaHV-1 gH/gL and gB 517 coexpression (Fig. 7) . Point mutations in this region did not refine the site further (Fig. 7) . 518
Deletion of the HSV-1 or SaHV-1 PFD or deletion of just the seven N-terminal residues 519 of the SaHV-1 gD PFD (pQF156) inhibited fusion, supporting the critical nature of this 520 region for gD function (Fig. 8) . The PFD may be the site of physical interaction with 521 gH/gL or the PFD may support the structure of a secondary gH/gL interaction site on gD. 522
Although these residues at the N-terminus of the PFD play an important role in 523 the homotypic requirements of gD, the homotypic specificity did not map exclusively to 524 this site. The context of the gD molecule influenced the outcome. For example, when 525 the seven N-terminal residues of the PFD of SaHV-1 gD were replaced by the 526 corresponding HSV-1 gD residues (pQF152), the gD chimera did not gain the ability to 527 functionally interact with HSV-1 entry glycoproteins and, in fact, retained the ability to 528 functionally interact with SaHV-1 entry glycoproteins (Fig. 7) . In our unpublished 529 experiments, peptides derived from the HSV-1 and SaHV-1 PFD failed to inhibit HSV-1 530 and SaHV-1 fusion. The local environment of the PFD likely influences its structure and 531
function. 532
on August 30, 2017 by guest http://jvi.asm.org/
Downloaded from
The receptor-binding region of the parainfluenza virus 5 HN protein is 533 dispensable for F protein activation (49). In contrast, we found that deletion of the 534 receptor-binding region of gD abrogates fusion (Fig. 9) . The gD PFD alone was 535 insufficient to promote fusion. Coexpression of PFD-deleted gD constructs did not 536 rescue the function of the gD molecules lacking a receptor-binding region. In these 537 experiments, the gD receptor-binding function could not be encoded on a separate 538 protein than the PFD, possibly because of the conformational changes that must occur 539 after receptor-binding. Interestingly, coexpression of the PFD-only constructs with wild-540 type gD inhibited fusion, suggesting that the PFD may compete with wild-type for a 541 critical binding site on one of the entry glycoproteins. 542
This study provides evidence for a functional interaction between gD and gH/gL 543 involving residues within the PFD. Future experiments will attempt to demonstrate a 544 physical interaction between gD and gH/gL that maps to the site defined in this work. 545
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